CLINICAL IMPROVEMENT IN PATIENTS WITH EXERCISE INDUCED PULMONARY ARTERY HYPERTENSION AFTER 6 MONTHS OF PHOSPHODIESTERASE-5 INHIBITORS OR ENDOTHELIAL RECEPTOR ANTAGONISTS OR BOTH

被引：0
|
作者：
Mannem, Santhosh R. [1 ]
Salamon, Jason [1 ]
Gunda, Sampath [1 ]
Iqbal, Muhammed [1 ]
Bhandari, Manoj [1 ]
Mazurek, Jeremy [1 ]
Zolty, Ronald [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)61663-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1197-357
引用
收藏
页码：A1660 / A1660
页数：1
相关论文
共 33 条
  • [1] Oral Therapies for Pulmonary Arterial Hypertension Endothelin Receptor Antagonists and Phosphodiesterase-5 Inhibitors
    Channick, Richard
    Preston, Iona
    Klinger, James R.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 811 - +
  • [2] Role and Effect of Phosphodiesterase-5 Inhibitors and Endothelin Receptor Antagonists in the Treatment of Moderate Pulmonary Hypertension
    Jabuonski, Thiago
    Mazurek, Jeremy A.
    Zolty, Ronald
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S64 - S64
  • [3] Predictors of the response to combined therapy with phosphodiesterase-5 inhibitors and endothelin receptor antagonists in pulmonary arterial hypertension
    Garcia, A. R.
    Blanco, I.
    Lopez Meseguer, M.
    Domingo Morera, J. A.
    Martin Ontiyuelo, C.
    Tura Ceide, O.
    Otero Gonzalez, I.
    Escribano Subias, P.
    Albert Barbera, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [4] Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil
    Schroll, Stephan
    Sebah, Daniela
    Wagner, Michael
    Popara, Viktoria
    Pfeifer, Michael
    Blumberg, Friedrich
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 186 (01) : 61 - 64
  • [5] CLINICAL IMPROVEMENT IN PATIENTS WITH EXERCISE INDUCED PULMONARY ARTERY HYPERTENSION IS SIMILAR TO PULMONARY ARTERIAL HYPERTENSION
    Mannem, Santhosh R.
    Salamon, Jason
    Gunda, Sampath
    Iqbal, Muhammad
    Bhandari, Manoj
    Mazurek, Jeremy
    Zolty, Ronald
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1498 - A1498
  • [6] Switching to Riociguat from Phosphodiesterase-5 Inhibitors, With or Without Endothelin Receptor Antagonists, in Patients with Pulmonary Arterial Hypertension: Results from the REPLACE Study
    Meyer, G. M. Bohns
    Al Hiti, H.
    Gruenig, E.
    Hoeper, M.
    Langleben, D.
    Pulido, T.
    Rosenkranz, S.
    Simonneau, G.
    White, R. J.
    Rahner, C.
    Meier, C.
    Bansilal, S.
    Ghofrani, H-A
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Survival of Japanese Patients with Pulmonary Arterial Hypertension after the Introduction of Endothelin Receptor Antagonists and/or Phosphodiesterase Type-5 Inhibitors
    Sakao, Seiichiro
    Tanabe, Nobuhiro
    Kasahara, Yasunori
    Tatsumi, Koichiro
    INTERNAL MEDICINE, 2012, 51 (19) : 2721 - 2726
  • [8] RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
    Hoeper, Marius M.
    Simonneau, Gerald
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Jansa, Pavel
    Rosenkranz, Stephan
    Scelsi, Laura
    Gruenig, Ekkehard
    Vizza, Carmine Dario
    Chang, MiKyung
    Colorado, Pablo
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (03)
  • [9] Comparison Between Phosphodiesterase-5 And Fibroblast Growth Factor Receptor-1 Inhibitors In Monocrotaline-Induced Pulmonary Arterial Hypertension
    Felix, N. S.
    Mendonca, L.
    Silva, J.
    Samary, C. D. S.
    Cruz, F. F.
    Rocha, N.
    Sudo, G.
    Rocco, P. R. M.
    Silva, P. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [10] Distinct Effects Of Phosphodiesterase-5 And Fibroblast Growth Factor Receptor-1 Inhibitors In Monocrotaline-Induced Pulmonary Arterial Hypertension
    Felix, N. S.
    Mendonca, L.
    Da Silva, J. S.
    Braga, C. L.
    Samary, C. S.
    Cruz, F. F.
    Rocha, N. N.
    Zapata-Sudo, G.
    Rocco, P. R. M.
    Silva, P. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
1234